Genomma Lab Internacional, S.A.B. de C.V. (BMV:LAB.B)
Mexico · Delayed Price · Currency is MXN 14.52
+0.11 (0.76%)
At close: Jul 22, 2026
Genomma Lab Internacional Cash Flow Statement
Financials in millions MXN. Fiscal year is January - December.
Millions MXN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,629 | 1,614 | 1,493 | 1,026 | 1,366 | 1,308 |
Depreciation & Amortization | 371.17 | 379.14 | 359.59 | 227.3 | 227.13 | 170.27 |
Other Amortization | 18.82 | 18.82 | 11.98 | 15.52 | 8.05 | 12.12 |
Loss (Gain) From Sale of Assets | 2.28 | - | - | - | - | - |
Asset Writedown & Restructuring Costs | 22.62 | 45.18 | 34.22 | 26.95 | 24.01 | 9.78 |
Loss (Gain) on Equity Investments | - | - | - | - | -22.75 | 90.38 |
Stock-Based Compensation | -0.02 | - | - | - | - | - |
Other Operating Activities | 987.88 | 775.7 | 1,006 | 366.66 | 725.41 | 689.34 |
Change in Accounts Receivable | -438.22 | -524.04 | -461.59 | 100.11 | -206.05 | -245.28 |
Change in Inventory | 73.94 | 22.03 | -242.7 | -164.18 | -434.59 | -227.6 |
Change in Accounts Payable | -97.06 | 15.38 | -112.54 | 280.29 | 453.63 | -171.81 |
Change in Other Net Operating Assets | -617.41 | -291.67 | 347.48 | 309.45 | -86.5 | -166.71 |
Operating Cash Flow | 1,850 | 2,055 | 3,034 | 2,247 | 2,055 | 1,468 |
Operating Cash Flow Growth | -40.45% | -32.28% | 35.01% | 9.35% | 39.94% | -14.36% |
Capital Expenditures | -470.64 | -547.93 | -270.81 | -238.44 | -402.96 | -630.21 |
Sale of Property, Plant & Equipment | 60.66 | 10.8 | 15.42 | 13.11 | 22 | 5.9 |
Cash Acquisitions | -148.33 | -144.19 | - | - | - | - |
Sale (Purchase) of Intangibles | -31.86 | -26.69 | -675.03 | -88.9 | -19.47 | -206.58 |
Investment in Securities | -178.58 | -158.64 | 92.41 | -144.9 | -205.93 | - |
Other Investing Activities | 145.31 | 113.85 | 106.04 | 156.91 | 118.14 | 65.27 |
Investing Cash Flow | -743.6 | -752.8 | -731.97 | -302.21 | -488.22 | -765.62 |
Long-Term Debt Issued | - | 5,031 | 4,276 | 5,494 | 4,315 | 2,054 |
Long-Term Debt Repaid | - | -3,895 | -4,241 | -5,616 | -3,867 | -2,634 |
Net Debt Issued (Repaid) | 522.51 | 1,137 | 34.89 | -122.28 | 448.13 | -579.9 |
Issuance of Common Stock | 1,790 | 1,826 | 1,674 | 1,742 | 460.27 | 76.9 |
Repurchase of Common Stock | -1,850 | -1,875 | -1,663 | -1,904 | -994.92 | -155.81 |
Common Dividends Paid | -976.72 | -781.77 | -778.82 | -580.7 | -777.66 | -391.76 |
Other Financing Activities | -717.72 | -781.34 | -858.22 | -811.57 | -498.2 | -418.68 |
Financing Cash Flow | -1,232 | -475.4 | -1,591 | -1,677 | -1,362 | -1,469 |
Foreign Exchange Rate Adjustments | -132.32 | -256.66 | 90.82 | -77.59 | -171.06 | -72.54 |
Net Cash Flow | -258.19 | 569.68 | 801.53 | 190.39 | 33.11 | -839.04 |
Free Cash Flow | 1,379 | 1,507 | 2,763 | 2,009 | 1,652 | 838.14 |
Free Cash Flow Growth | -49.01% | -45.47% | 37.56% | 21.60% | 97.08% | -17.64% |
Free Cash Flow Margin | 8.09% | 8.59% | 14.85% | 12.20% | 9.82% | 5.41% |
Free Cash Flow Per Share | 1.41 | 1.54 | 2.82 | 2.10 | 1.66 | 0.83 |
Cash Interest Paid | 546.16 | 781.34 | 858.22 | 811.57 | 509.09 | 418.68 |
Cash Income Tax Paid | 647.94 | 917.82 | 808.79 | 981.14 | 706.13 | 838.05 |
Levered Free Cash Flow | 611.51 | 615.26 | 1,220 | 2,387 | 1,829 | 525.7 |
Unlevered Free Cash Flow | 1,053 | 1,094 | 1,763 | 2,890 | 2,149 | 791.33 |
Change in Working Capital | -1,182 | -778.3 | -469.36 | 525.67 | -273.51 | -811.4 |